{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-23-265233","form_type":"8-K","ticker":"XOMA","cik":"0000791908","company_name":"XOMA Royalty Corp","filed_at":"2023-10-27T23:59:59+00:00","discovered_at":"2026-05-14T18:03:32.014853+00:00","generated_at":"2026-06-09T07:29:44.183547+00:00","sec_items":["1.02"],"event_type":"other_material","sentiment":"negative","materiality_score":0.7,"calibrated_materiality_score":0.7,"confidence":"high","headline":"Organon terminates ebopiprant license agreement with XOMA; XOMA to seek new partner","bullets":["Organon notified XOMA of intent to terminate License Agreement for ebopiprant; effective Jan 21, 2024.","Termination is for convenience; no milestone payments for achievements after notice; no early termination penalties.","XOMA to seek to out-license ebopiprant for further development.","License agreement originally between Organon and ObsEva (July 2021), assumed by XOMA in Nov 2022."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-23-265233","json":"https://secwatch.observer/filing/0001193125-23-265233.json","markdown":"https://secwatch.observer/filing/0001193125-23-265233.md","text":"https://secwatch.observer/filing/0001193125-23-265233.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/791908/000119312523265233/0001193125-23-265233-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/791908/000119312523265233/d552854d8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-09T07:29:44.183547+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"19d9296c0a18b34a2e76d99e156170a95ee64c27","claim":"XOMA Royalty Corp terminated License Agreement (ebopiprant) with Organon International GmbH valued at Termination for convenience; no material penalties; Company to seek out-license (effective 2023-10-23).","evidence_excerpt":"On October 23, 2023, Organon International GmbH (“Organon”), notified XOMA Corporation (the “Company”) of its intent to terminate for convenience that certain License Agreement, by and between Organon and ObsEva SA (“ObsEva”), dated July 26, 2021 (the “License Agreement”).","evidence_source":"SEC 8-K Item 1.01/1.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/791908/000119312523265233/0001193125-23-265233-index.htm","confidence":0.95,"family_label":"Material Agreements","details":[{"label":"Action","value":"termination"},{"label":"Agreement","value":"license"},{"label":"Counterparty","value":"Organon International GmbH"},{"label":"Value","value":"Termination for convenience; no material penalties; Company to seek out-license"},{"label":"Effective","value":"2023-10-23"}],"fact_type":"material_agreement"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}